• / Free eNewsletters & Magazine
  • / My Account
Home>Valeant rejected takeover bid from Takeda, TPG: report

Valeant rejected takeover bid from Takeda, TPG: report

3party Content

Fri, 27 May 2016

By David Benoit , Dana Mattioli and Jonathan D. Rockoff Offer made more than a month ago shows beleaguered company still has value Valeant Pharmaceuticals International Inc. received a joint takeover approach this spring from Japan's Takeda Pharmaceutical Co. (4502.TO) and private-equity firm TPG
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.